Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone + tadalafil for hypoactive sexual desire disorder in women
2011-002770-23Phase 2Active
- Sponsor
- Emotional Brain
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypoactive sexual desire disorder (HSDD) comparing testosterone + tadalafil with placebo (2 arms). Primary endpoint: Increase in sexual satisfaction of a single coital event. Started Jun 2011; status: active.
02
Drugs
testosteronetadalafil
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on 2011-002770-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002770-23.